Study to Evaluate the Efficacy of Immunosuppression in Myocarditis or Inflammatory Cardiomyopathy.
A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 100 participants.
Also called NCT04654988
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT04654988 -
2020-003877-23
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Poland
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04654988. Randomized; quadruple masking; primary purpose treatment. Start 2022-12-01 (actual); primary completion 2027-09-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study to Evaluate the Efficacy of Immunosuppression in Myocarditis or Inflammatory Cardiomyopathy.
- Acronym
- IMPROVE-MC
- Condition
- Myocarditis
- Condition
- Heart Failure
- Condition
- Endomyocardial Biopsy
- Condition
- Cardiomyopathies, Secondary
- Condition
- Immunosuppression
- Intervention (Drug)
- Prednisone
- Intervention (Drug)
- Azathioprine
- Intervention (Drug)
- Placebo Prednisone
- Intervention (Drug)
- Placebo Azathioprine
- Lead sponsor
- Medical University of Warsaw
Record details
- Record id
cardio:ct-nct04654988- Content hash
6c22fff3926df25ee91c18375630134fe20c08398fb05204f13266e24219c356